Literature DB >> 13252186

Pressor substances in arterial hypertension. V. Chemical and pharmacological characteristics of pherentasin.

H A SCHROEDER, H M PERRY, E G DENNIS, L E MAHONEY.   

Abstract

Some pharmacological and chemical qualities of pherentasin, a vasoconstrictor substance procured from human hypertensive blood, were studied by a new assay method using the spirally cut rabbit aorta. Of a number of drugs tested, six metal-binding agents including hydralazine inactivated the active principle. The material was stable in acid but not in alkali. It was destroyed by drying. Chemical analysis and inactivation procedures suggested the presence of primary amine and considerable sulfur; a peptide linkage was suspected because of inactivation by manganous ion and papain. The material was remarkably resistant to most pharmacological agents and appeared to act directly on smooth muscle.

Entities:  

Keywords:  BLOOD; HYPERTENSION/blood in; VASOMOTOR DRUGS/therapeutic use

Mesh:

Substances:

Year:  1955        PMID: 13252186      PMCID: PMC2136506          DOI: 10.1084/jem.102.3.319

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs.

Authors:  R F FURCHGOTT; S BHADRAKOM
Journal:  J Pharmacol Exp Ther       Date:  1953-06       Impact factor: 4.030

2.  Studies on the control of hypertension by hyphex. III. Pharmacological and chemical observations on 1-hydrazinophthalazine.

Authors:  H M PERRY; H A SCHROEDER; G S GOLDSTEIN; E M MENHARD
Journal:  Am J Med Sci       Date:  1954-10       Impact factor: 2.378

3.  Management of arterial hypertension.

Authors:  H A SCHROEDER
Journal:  Am J Med       Date:  1954-10       Impact factor: 4.965

4.  Pressor substances in arterial hypertension. IV. Quantitative and qualitative studies of pherentasin.

Authors:  D F DAVIES; N S OLSEN; H A SCHROEDER
Journal:  Circulation       Date:  1952-03       Impact factor: 29.690

5.  [Inhibition of histaminase by phthalazin derivatives].

Authors:  F GROSS; W SCHULER; J TRIPOD; R MEIER
Journal:  Experientia       Date:  1952-06-15

6.  Pherentasin: a pressor substance present in arterial hypertension.

Authors:  H A SCHROEDER; N S OLSEN
Journal:  J Clin Invest       Date:  1950-06       Impact factor: 14.808

7.  Pressor substances in arterial hypertension; activity and amine content of crude extracts of blood.

Authors:  C C STOCK; H A SCHROEDER
Journal:  Am J Physiol       Date:  1950-02

8.  Pressor substances in arterial hypertension. III. Chemical studies on pherentasin.

Authors:  N S OLSEN; H A SCHROEDER
Journal:  J Exp Med       Date:  1950-12       Impact factor: 14.307

9.  Pressor substances in arterial hypertension. II. Demonstration of pherentasin, a vasoactive material procured from blood.

Authors:  H A SCHROEDER; N S OLSEN
Journal:  J Exp Med       Date:  1950-12       Impact factor: 14.307

  9 in total
  1 in total

Review 1.  Cardiovascular toxicities upon manganese exposure.

Authors:  Yueming Jiang; Wei Zheng
Journal:  Cardiovasc Toxicol       Date:  2005       Impact factor: 3.231

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.